Triple
T22457850
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | ICH CTD |
E555159
|
entity |
| Predicate | fullName |
P16
|
FINISHED |
| Object | International Council for Harmonisation Common Technical Document |
—
|
NE NERFINISHED |
How this triple was built (2 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: International Council for Harmonisation Common Technical Document | Statement: [ICH CTD, fullName, International Council for Harmonisation Common Technical Document]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: International Council for Harmonisation Common Technical Document Context triple: [ICH CTD, fullName, International Council for Harmonisation Common Technical Document]
-
A.
ICH E6 Good Clinical Practice
ICH E6 Good Clinical Practice is an international ethical and scientific quality standard that governs the design, conduct, recording, and reporting of clinical trials involving human subjects.
-
B.
ICH M4 Common Technical Document
chosen
ICH M4 Common Technical Document is an internationally harmonized format and set of guidelines for organizing and submitting regulatory information on the quality, safety, and efficacy of pharmaceuticals to health authorities.
-
C.
International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use
The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is a global body that develops and promotes unified scientific and technical standards to ensure the safety, quality, and efficacy of medicines worldwide.
-
D.
ICH Q8 Pharmaceutical Development
ICH Q8 Pharmaceutical Development is an international guideline that outlines a systematic, science- and risk-based approach to pharmaceutical product and process development, forming a core part of the ICH quality framework.
-
E.
ICH Q11 Development and Manufacture of Drug Substances
ICH Q11 Development and Manufacture of Drug Substances is an ICH guideline that provides principles and expectations for the development and manufacturing of chemical and biotechnological drug substances within a quality-by-design framework.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
Provenance (2 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69e11e51fdec8190adfdf9f8a6362221 |
completed | April 16, 2026, 5:37 p.m. |
| NER | Named-entity recognition | batch_69f15b7d00208190955a70e2c22d25a4 |
completed | April 29, 2026, 1:14 a.m. |
Created at: April 16, 2026, 8:48 p.m.